Mechanisms of cancer evolution and drivers of tumour heterogeneity
Cancer drug resistance is almost inevitable in the majority of patients with advanced metastatic tumours. Intra-tumour heterogeneity, facilitating rapid tumour evolution, is a main cause of resistance to cancer therapies. In this thesis, I explore how cancer genome sequencing data can shed light int...
Main Author: | |
---|---|
Published: |
University College London (University of London)
2015
|
Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.755981 |